"How much did you invest previously?" Ye Tian asked.
"I've already withdrawn nearly forty billion, and my funds are about to run out. There are two options now: one is to withdraw, losing the principal. The other is to keep fighting until we win. Of course, the second option is risky," Ou Fan replied.
Ye Tian thought for a moment and said, "Wait a moment, I'll contact a friend. He might be able to help."
He moved to a secluded spot and called Wu Zongnian, explaining the situation truthfully.
"Ask him which stocks it is," Wu Zongnian said.
Ye Tian inquired and then relayed the information.
After hearing it, Wu Zongnian stated, "This is clearly a setup by the other party. No matter how much more money you put in, they will buy it all up."
"Why? Do they have an endless supply of money?" Ye Tian asked.
"I'm familiar with this matter. The people behind this setup are the leaders of two major North American conglomerates, possessing trillions of US dollars in cash flow. You cannot compete with them."
"So, does this mean we can only cut our losses and leave?" Ye Tian asked.
"There's no need to cut losses. You can operate in reverse to hedge the losses."
"I don't understand finance. Just make sure there are no losses on this side," Ye Tian said.
"There might be some losses, but they won't exceed five percent. How about this, have her communicate with me directly."
Afterward, Ye Tian explained the situation. Ou Fan smiled wryly, "So it was indeed someone else's setup. If the loss is within five percent, that's acceptable."
Then, she began communicating with Wu Zongnian.
Through his interactions with everyone, Ye Tian also learned about the backgrounds of these twelve individuals. None of them were ordinary people. Their combined influence was considerable.
Among the Twelve Apostles, some were in the internet business. For instance, Ou Fan was involved in internet finance, also touching upon e-commerce. Zhou Tianxing primarily focused on social software and gaming.
There was also a financial magnate named Huang Zilong. Huang Zilong ranked among the top three in China in futures and fund securities. He had also established an angel fund, investing in many well-known domestic companies.
Huang Zilong, not yet fifty, was very low-key among the Twelve Apostles and had barely spoken before. At this moment, he sat next to Ye Tian and smiled, "Mr. Ye, I heard just now that your Baozhi Company also intends to go public. I have considerable experience in company listings. If you need anything, Zilong will do his utmost to assist."
Regarding the company's listing, Yang Shoucheng had been preparing him for it. He asked, "Boss Huang, what do you think my Baozhi Company is worth?"
Huang Zilong smiled, "Given your company's current high-end image and dominant position in the cosmetic and skincare sector, the price-to-earnings ratio can be pushed to over fifty! Of course, it ultimately depends on the company's growth potential. If the potential is high and growth is fast, even a hundred times the P/E ratio is possible."
Ye Tian pondered, "The company should have a profit of fifty billion this year. Next year, it's highly likely to exceed one hundred billion. According to you, Baozhi Company's market value could reach five trillion?"
"Five trillion is not uncommon. There are quite a few companies in the ten trillion range in North America. If we perform exceptionally well, reaching ten trillion is not impossible."
He expressed great interest in Baozhi Company, saying, "If your company goes public, I hope to subscribe to a portion if possible."
Ye Tian smiled, "We can discuss that."
Huang Zilong was pleased. "I have researched your company, but some things are still unclear. I wonder if new products will be released in the future?"
"On average, every two years, we will launch one drug and one health supplement, along with two skincare and beauty products," Ye Tian replied.
Huang Zilong's eyes lit up. "If all of them become bestsellers, Baozhi Company's future revenue might break through one trillion!"
"One trillion is just the starting point. Our products will be sold in North America this year, with the first two years' revenue estimated at around one hundred and fifty billion. Furthermore, Europe is also preparing for our launch."
"What is the current production status of the latest face cream, eye cream, and wrinkle cream? And the medication for diabetes?"